Xamoterol in severe heart failure
- 1 July 1990
- journal article
- medical science
- Published by Elsevier in The Lancet
- Vol. 336 (8706) , 1-6
- https://doi.org/10.1016/0140-6736(90)91517-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.Circulation, 1989
- The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.Published by Wiley ,1989
- Effects of captopril on survival in patients with heart failureThe American Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.Circulation, 1987
- Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.Heart, 1985
- Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarctionThe American Journal of Cardiology, 1983
- THE CARDIOVASCULAR EFFECTS OF ICI 118,587: A β1‐ADRENOCEPTOR PARTIAL AGONISTBritish Journal of Pharmacology, 1982